GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shanghai Pioneer Holding Ltd (HKSE:01345) » Definitions » EV-to-EBIT

Shanghai Pioneer Holding (HKSE:01345) EV-to-EBIT : 11.35 (As of May. 03, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pioneer Holding EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Shanghai Pioneer Holding's Enterprise Value is HK$2,272 Mil. Shanghai Pioneer Holding's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$200 Mil. Therefore, Shanghai Pioneer Holding's EV-to-EBIT for today is 11.35.

The historical rank and industry rank for Shanghai Pioneer Holding's EV-to-EBIT or its related term are showing as below:

HKSE:01345' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.65   Med: 9.01   Max: 23.03
Current: 11.29

During the past 12 years, the highest EV-to-EBIT of Shanghai Pioneer Holding was 23.03. The lowest was 1.65. And the median was 9.01.

HKSE:01345's EV-to-EBIT is ranked better than
73.54% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 18.59 vs HKSE:01345: 11.29

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Shanghai Pioneer Holding's Enterprise Value for the quarter that ended in Dec. 2023 was HK$2,258 Mil. Shanghai Pioneer Holding's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$200 Mil. Shanghai Pioneer Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 8.86%.


Shanghai Pioneer Holding EV-to-EBIT Historical Data

The historical data trend for Shanghai Pioneer Holding's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pioneer Holding EV-to-EBIT Chart

Shanghai Pioneer Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.57 8.12 6.59 7.58 11.29

Shanghai Pioneer Holding Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.59 - 7.58 - 11.29

Competitive Comparison of Shanghai Pioneer Holding's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Shanghai Pioneer Holding's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pioneer Holding's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Shanghai Pioneer Holding's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shanghai Pioneer Holding's EV-to-EBIT falls into.



Shanghai Pioneer Holding EV-to-EBIT Calculation

Shanghai Pioneer Holding's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2271.826/200.081
=11.35

Shanghai Pioneer Holding's current Enterprise Value is HK$2,272 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai Pioneer Holding's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$200 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Pioneer Holding  (HKSE:01345) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Shanghai Pioneer Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=200.081/2258.3845
=8.86 %

Shanghai Pioneer Holding's Enterprise Value for the quarter that ended in Dec. 2023 was HK$2,258 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai Pioneer Holding's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$200 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Pioneer Holding EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Shanghai Pioneer Holding's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pioneer Holding (HKSE:01345) Business Description

Traded in Other Exchanges
N/A
Address
No.15, Lane 88 Wuwei Road, Putuo District, Shanghai, CHN, 200331
Shanghai Pioneer Holding Ltd is an investment holding company. It is engaged in the marketing, promotion, sales, and channel management service for pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, orthopedics, odontology, and wound care. The majority of its revenue derives from the Sales of pharmaceutical products segment. The group operates mainly in PRC.

Shanghai Pioneer Holding (HKSE:01345) Headlines

No Headlines